Director, Search and Evaluation, Cell Therapy and Rare Disease @ (March 2024 - November 2025)
Head of Scientific Competitive Intelligence and Knowledge Management @ (April 2021 - September 2023)
Head of Search and Evaluation – Digital and AI technologies @ (January 2019 - April 2021)
Head, Cell and Gene Therapy - External Innovation @ (January 2015 - December 2018)
Director, Global Licensing and Business Development @ (January 2014 - December 2015)
Global Head, Cross Division Innovation – External Innovation @ (June 2012 - December 2013)
Sr. Director, Science and Technology @ (July 2011 - June 2012)
Director, Innovation and Strategy – Stem Cell Innovation Program @ (July 2010 - June 2011)
Director, Strategic Marketing @ (October 2004 - July 2010)
Scientific Director @ Upstate Biotechnology (January 2004 - January 2005)
Scientist, Drug Discovery @ (January 2001 - January 2004)
Jeff Till Education
Stony Brook University
PhD (Molecular and Cellular Biochemistry)
Jeff Till Summary
Jeff Till, based in Boston, MA, US, is currently a Sr. Director, Strategy - Immunology at AstraZeneca. Jeff Till brings experience from previous roles at Novo Nordisk, EMD Serono, Inc. and EMD Serono. Jeff Till holds a PhD in Molecular and Cellular Biochemistry @ Stony Brook University. Jeff Till has 3 mobile phone numbers on RocketReach.
Looking for a different Jeff Till?
Find contact details for 700 million professionals.